ASCGX | VEXPX | ASCGX / VEXPX | |
Total Expense Ratio | 2.48 | 0.44 | 564% |
Annual Report Gross Expense Ratio | 2.48 | 0.44 | 564% |
Fund Existence | 21 years | 58 years | - |
Gain YTD | 2.587 | 1.235 | 209% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 3000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 16.8M | 19.9B | 0% |
Annual Yield % from dividends | 1.25 | 0.40 | 312% |
Returns for 1 year | 11.92 | -1.90 | -628% |
Returns for 3 years | 11.98 | 5.40 | 222% |
Returns for 5 years | -16.45 | 5.07 | -324% |
Returns for 10 years | 0.40 | 19.92 | 2% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
HQL | 13.86 | 0.21 | +1.54% |
abrdn Life Sciences Investors | |||
ZTWO | 50.78 | -0.01 | -0.02% |
F/M 2-Yr Invmt Grd Corp Bd ETF | |||
SEPP | 29.14 | -0.02 | -0.07% |
PGIM S&P 500 Buffer 12 ETF - Sep | |||
DEM | 46.16 | -0.10 | -0.22% |
WisdomTree Emerging Markets High Div ETF | |||
STXT | 20.16 | -0.09 | -0.44% |
Strive Total Return Bond ETF |